Eq: Large Cap
(New York)
While Treasury yields, especially at the short end of the curve, have improved a great deal recently. Many investors may still be interested in adding some stocks with good dividends to their portfolios. With that in mind, pharma may be a great place to look. The sector is having a tough time this year—down over 6% to-date—but that means dividend yields are looking strong. The sector is averaging 2.9%, but the best payers are near 4%, including some big names. For instance, AbbVie and Pfizer are both yielding 3.7% or over, and both seem to have rock solid outlooks where that dividend is not going to shrink.
FINSUM: These seem to be some great choices. The risk here does not appear to be in the fundamentals, but more related to interest rates.
(New York)
Retail has been stuck in a rut for some years. Big retailers have been closing stores left and right, so unless you are a contrarian, it is a tough time to invest in the sector. However, there is an ETF that might offer the best way to play the current environment. That ETF is called Amplify Online Retail (IBUY). IBUY has returned just over 15% this year, and tracks an index of companies that make at least 70% of their revenue from online or virtual sales. Three quarters of its holdings are in the US. Only about 10% of retail sales happen online in the US, but that is expected to double over the next five years.
FINSUM: If you are a believer in ecommerce’s ability to disrupt the predominant retail model and make profit, then this seems like a good way to play the sector.
(New York)
Small cap stocks have done well this year, and many are growing more interested in the area following underperformance in the last few years. With that in mind, here are some picks from a top global small caps fund manager. The first thing to know is that international small caps are one of the few areas where active management adds value because many companies are poorly covered by analysts. The other thing to know is that at small caps the CEO really makes a difference in a way that is impossible at much larger organizations. The manager picks shares like Japan’s Horiba, or ABC-MART, or Britain’s Electrocomponents.
FINSUM: Picking international small caps is definitely an area where management needs to be outsourced to a specialist, and to be honest, this fund’s (Vanguard FTSE All-World ex-US Small-Cap) picks and approach were to us impressive.
More...
(New York)
All the press is on the growth of ETFs, but today some surprise data has come out—mutual fund inflows are outpacing ETFs this year, at least according to Pershing. So far this year mutual funds on Pershing’s platform have seen about $8 bn of inflows, while ETFs have seen just over $6 bn. The explanation for the trend, according to BNY Mellon Pershing is that “As advisors look to diversify their investment strategies to actively manage against emerging risks in the market, we are starting to see mutual fund inflows close the gap with ETFs”.
FINSUM: Active management and once-a-day liquidity do seem to give mutual funds an advantage in the risk avoidance department.
(New York)
One of the things the growing ETF markets lacks is many options regarding private equity, and with good reason. The returns of the sector are hard to reproduce with publicly traded stocks. But getting private equity returns can be difficult to attain anyway because of the challenges of investing in the sector, especially for investors who are not at the wealthiest end of the spectrum. However, there are two newish ETFs on the market, BUYN and BUY, which use an investing methodology developed at Harvard to try to replicate the returns of the private equity sector. The provider is SummerHaven, who comments about their funds that “We believe that these ETFs based on our private equity strategy indexes will provide investors with an opportunity to access returns comparable to an asset class that has traditionally only been available through private markets, with the added benefit of liquidity and transparent and without lockups, vintage risk, investment minimums or takeover premiums. These ETFs will allow both retail and institutional investors an opportunity to access private equity strategy returns at substantially lower fees”.
FINSUM: On paper these sound like an interesting option, but only time will tell if the strategy actually achieves what it says. The ETFs are especially unproven because the Harvard paper which underpins the strategy was only published last year.
(New York)
Are you on the look out for income stocks? While their position in one’s portfolio is changing given rising rates, good income stocks, especially safe ones, are always of value. The S&P 500 is currently only yielding about 2%, which is now less than two-year Treasuries. However, one can find very strong stocks with 3-4% yields. Those include Target and Qualcomm, the latter of which is yielding 4.2% and is a very well-covered stock. Also check out Seagate, CenturyLink, Pitney Bowes, and Navient.
FINSUM: These picks come from what seems to be a very diligent dividend-focused manager that was recently profiled in Barron’s. Our big question is how much dividend stocks might suffer in a rising rate period.